These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24944678)

  • 1. Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy.
    Gao Z; Meng X; Mu D; Sun X; Yu J
    Oncol Lett; 2014 Apr; 7(4):1118-1122. PubMed ID: 24944678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of celiac lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    Chen YH; Lu HI; Wang YM; Lo CM; Chou SY; Huang CH; Shih LH; Chen SW; Li SH
    Oncotarget; 2017 Nov; 8(56):96190-96202. PubMed ID: 29221198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Different Chemotherapy Regimens in Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
    Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Li SH
    J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Huang CC; Shih LH; Chen SW; Li SH
    BMC Cancer; 2018 Aug; 18(1):837. PubMed ID: 30126380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
    Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
    Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinoma.
    Lin G; Sun XJ; Han QB; Wang Z; Xu YP; Gu JL; Wu W; Zhang GU; Hu JL; Sun WY; Mao WM
    Oncol Lett; 2015 Aug; 10(2):901-906. PubMed ID: 26622592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
    Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Huang CH; Shih LH; Chen SW; Li SH
    PLoS One; 2018; 13(6):e0198800. PubMed ID: 29889869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of periostin and EGFR in patients with esophageal squamous cell carcinoma and their prognostic significance.
    Jia W; Wang W; Ji CS; Niu JY; Lv YJ; Zhou HC; Hu B
    Onco Targets Ther; 2016; 9():5133-42. PubMed ID: 27574454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF as a predictor for response to definitive chemoradiotherapy and COX-2 as a prognosticator for survival in esophageal squamous cell carcinoma.
    Yoon MS; Nam TK; Lee JS; Cho SH; Song JY; Ahn SJ; Chung IJ; Jeong JU; Chung WK; Nah BS
    J Korean Med Sci; 2011 Apr; 26(4):513-20. PubMed ID: 21468258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients.
    Hu G; Wang Z; Wang Y; Zhang Q; Tang N; Guo J; Liu L; Han X
    Drug Des Devel Ther; 2016; 10():2129-36. PubMed ID: 27445460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
    Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
    Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Ku80 suggests poor prognosis of locally advanced esophageal squamous cell carcinoma patients.
    Wang S; Wang Z; Liu X; Liu Y; Jia Y
    World J Surg; 2015 Jul; 39(7):1773-81. PubMed ID: 25711486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neck Lymph Node Metastasis as A Poor Prognostic Factor in Thoracic Esophageal Squamous Cell Carcinoma Patients Receiving Concurrent Chemoradiotherapy: A Propensity Score-Matched Analysis.
    Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Shih LH; Chen SW; Li SH
    Sci Rep; 2018 Oct; 8(1):15073. PubMed ID: 30305678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study of postoperative radiotherapy for locally advanced esophageal squamous cell carcinoma.
    Zhang Z; Xu L; Di X; Zhang C; Ge X; Sun X
    Ann Palliat Med; 2019 Nov; 8(5):708-716. PubMed ID: 31865731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.
    Satake H; Tahara M; Mochizuki S; Kato K; Hara H; Yokota T; Kiyota N; Kii T; Chin K; Zenda S; Kojima T; Bando H; Yamazaki T; Iwasa S; Honma Y; Hamauchi S; Tsushima T; Ohtsu A
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):91-9. PubMed ID: 27193097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
    Zhou XL; Zhu WG; Zhu ZJ; Wang WW; Deng X; Tao WJ; Ji FZ; Tong YS
    Oncologist; 2019 Aug; 24(8):e677-e686. PubMed ID: 31040254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
    Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
    Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR Expression in Patients with Esophageal Squamous Cell Carcinoma and its Association with Pathologic Response to Preoperative Chemoradiotherapy: A Study in Northeastern Iran.
    Anvari K; Sima HR; Seilanian Toussi M; Anvari A; Shahidsales S; Memar B; Aledavoud SA; Forghani MN; Abdollahi A; Ghaffarzadegan K
    Arch Iran Med; 2017 Apr; 20(4):240-245. PubMed ID: 28412829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of prostaglandin E receptor 2 and epidermal growth factor receptor in esophageal squamous cell carcinoma patients with (pN+) regional lymph node metastasis.
    Luo HQ; He YF; Yan Y; Wu SS; Hu XX; Ke LH; Niu JY; Li HM; Xu HJ
    Transl Cancer Res; 2019 Aug; 8(4):1233-1241. PubMed ID: 35116865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of epidermal growth factor receptor mutation/copy number and K-ras mutation in esophageal cancer.
    Guo K; Wang WP; Jiang T; Wang JZ; Chen Z; Li Y; Zhou YA; Li XF; Lu Q; Zhang LJ
    J Thorac Dis; 2016 Jul; 8(7):1753-63. PubMed ID: 27499966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.